| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.42 | 3e-17 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-07 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |